Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Abeer Arain"'
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-9 (2021)
Abstract Background Cardiac metastasis due to colon cancer is extraordinarily uncommon. Given the rarity of diagnosis, there is paucity of evidence and hence, no established guidelines for evaluation or clinical management strategy. Clinical presenta
Externí odkaz:
https://doaj.org/article/5a691fad44f642489b8c29137c3ee15e
Publikováno v:
Chronic Diseases and Translational Medicine, Vol 4, Iss 3, Pp 148-155 (2018)
Hepatocellular carcinoma (HCC) is one of the most common cancers with high mortality worldwide. Treatment options for patients with advanced stage HCC remain a great challenge. However, novel agents especially small molecule tyrosine kinase inhibitor
Externí odkaz:
https://doaj.org/article/dd85b95f2f214bc6854270b02bc26dff
Publikováno v:
Kansas Journal of Medicine
Introduction We evaluated the knowledge of non-steroidal antiinflammatorydrugs (NSAIDs) including their dosage, side effects,contraindications, and drug interactions among the patients in anoutpatient rheumatology clinic. Methods Patients in a rheuma
Background: Cardiac metastasis due to colon cancer is extraordinarily uncommon. Given the rarity of diagnosis, there is paucity of evidence and hence, no established guidelines for evaluation or clinical management strategy. Clinical presentation: We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1176c0d707fc71f8eda59fc1e2003064
https://doi.org/10.21203/rs.3.rs-138793/v1
https://doi.org/10.21203/rs.3.rs-138793/v1
Autor:
Maen Abdelrahim, Ala Abudayyeh, Elene Abzianidze, Luna Acharya, Sarfraz Ahmad, Saeed Ali, Abeer Arain, Riyaz Basha, Lakkakula V.K.S. Bhaskar, Lorna A. Brudie, Anjali Chandra, Begum Dariya, Akpedje Dossou, Aimen Farooq, Batoul Farran, Rafal Fudala, V. Gayathri, Nnamdi I. Gwacham, Nathan Hannay, Sana Hussain, Anum Jalil, Sundas Jehanzeb, Ketevani Kankava, Deepak Kakara Gift Kumar, Eka Kvaratskhelia, Andras G. Lacko, Rama Rao Malla, Hariharasudan Mani, Rakshimitha Marni, Ezek Mathew, Vikas Venkata Mudgapalli, Ibrahim N. Muhsen, Santoshi Muppala, Bhavani Nagarajan, Ganji Purnachandra Nagaraju, Maya Nair, Thomas A. Paterniti, Kiranmayi Patnala, Alexandra M. Poch, Mamoon Ur Rashid, Nirupama Sabnis, Deepika Sarvepalli, Evan A. Schrader, Ishna Sharma, Kasey Shepp, Swathi Sridhar, Aditi Talkad, Aman Ullah, Henu Kumar Verma, Jesse Wayson, James Wert, Hammad Zafar, Effa Zahid, Amy Zheng
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9df2ec710df903049f34c56d3e630de
https://doi.org/10.1016/b978-0-12-824299-5.09987-1
https://doi.org/10.1016/b978-0-12-824299-5.09987-1
Autor:
Abeer Arain
Publikováno v:
Ecancermedicalscience. 15
As the second most common cause of mortality worldwide, cancer is now prevalent in our society. The overall number of cases continue to rise each year and given the advancements in treatment strategies we now have a large population of cancer survivo
Autor:
Abeer Arain
Publikováno v:
The breast journalREFERENCES. 26(12)
Publikováno v:
ecancermedicalscience
Acquired haemophilia is a severe haematological disorder characterised by the presence of anti-factor VIII antibodies. Although rare, it can lead to serious bleeding complications. Acquired haemophilia can be seen in patients with malignancies as a p
Publikováno v:
Journal of Clinical Oncology. 38:e15127-e15127
e15127 Background: Chronic Hepatitis B virus (HBV) impacts 257 million people worldwide. Chemo- and immunotherapies may predispose to HBV reactivation (HBVr), which can negatively impact oncologic outcomes. Programmed death (PD) and programmed death
Publikováno v:
Chronic Diseases and Translational Medicine
Chronic Diseases and Translational Medicine, Vol 4, Iss 3, Pp 148-155 (2018)
Chronic Diseases and Translational Medicine, Vol 4, Iss 3, Pp 148-155 (2018)
Hepatocellular carcinoma (HCC) is one of the most common cancers with high mortality worldwide. Treatment options for patients with advanced stage HCC remain a great challenge. However, novel agents especially small molecule tyrosine kinase inhibitor